0001317757-11-000015.txt : 20110525
0001317757-11-000015.hdr.sgml : 20110525
20110525170111
ACCESSION NUMBER: 0001317757-11-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110524
FILED AS OF DATE: 20110525
DATE AS OF CHANGE: 20110525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCOON DAVEY
CENTRAL INDEX KEY: 0001270110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 11871647
MAIL ADDRESS:
STREET 1: 12 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4
2011-05-24
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001270110
SCOON DAVEY
100 HAYDEN AVENUE
LEXINGTON
MA
02421
1
0
0
0
Stock Options
15.41
2011-05-24
4
A
0
3800
A
2021-05-24
Common Stock
3800
3800
D
Restricted Stock Units
2011-05-24
4
A
0
1900
0
A
Common Stock
1900
1900
D
Grant of stock option pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This option will vest and become exercisable in twelve equal monthly installments over one year from the date of grant.
Price is not applicable.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant will vest in equal monthly installments over one year from the date of grant; however, delivery of the shares is deferred until the earlier of (a) three years from the date of grant or (b) the date the reporting person no longer serves as a member of the Board of Directors of AMAG Pharmaceuticals, Inc.
Not applicable.
Joseph L. Farmer, attorney-in-fact
2011-05-25